NCT01786382View on ClinicalTrials.gov

A Drug Interaction Study of the Effects of PPI-668 on the Pharmacokinetics of Midazolam and Omeprazole

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Pharmacokinetic Assessments in Healthy Volunteers
Interventions
DRUG

PPI-668

DRUG

Midazolam

DRUG

Omeprazole

DRUG

Telaprevir

Trial Locations (1)

53095

Spaulding Clinical Research, West Bend

Sponsors
All Listed Sponsors
lead

Presidio Pharmaceuticals, Inc.

INDUSTRY

NCT01786382 - A Drug Interaction Study of the Effects of PPI-668 on the Pharmacokinetics of Midazolam and Omeprazole | Biotech Hunter | Biotech Hunter